Biomedical Engineering Reference
In-Depth Information
40. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma.
J Allergy Clin Immunol 2002; 109:615-620.
41. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov
SA, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative
stress in patients with COPD and healthy smokers. Am J Respir Crit Care
Med 2000; 162:1175-1177.
42. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled
ethane, a marker of lipid peroxidation, is elevated in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2000; 162:369-373.
43. Macnee W. Oxidants
=
antioxidants and COPD. Chest 2000; 117:303S-317S.
44. Poole PJ, Black PN. Preventing exacerbations of chronic bronchitis and
COPD: therapeutic potential of mucolytic agents. Am J Respir Med 2003; 2:
367-370.
45. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new
pharmacological approach in shock, inflammation, and ischemia
=
reperfusion
injury. Pharmacol Rev 2001; 53:135-159.
46. Chang LY, Subramaniam M, Yoder BA, Day BJ, Ellison MC, Sunday ME,
et al. A catalytic antioxidant attenuates alveolar structural remodeling in
bronchopulmonary dysplasia. Am J Respir Crit Care Med 2003; 167:57-64.
47. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reac-
tive nitrogen species production in chronic obstructive pulmonary disease
airways. Am J Resp Crit Care Med 2000; 160:701-706.
48. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM,
et al. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled
breath nitric oxide in healthy volunteers and asthmatics. FASEB J 2003;
17:1298-1300.
49. Sies H, Masumoto H. Ebselen as a glutathione peroxidase mimic and as a
scavenger of peroxynitrite. Adv Pharmacol 1997; 38:229-246.
50. Panina-Bordignon P, D'Ambrosio D. Chemokines and their receptors in
asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med
2003; 9:104-110.
51. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8
and tumor necrosis factor-
a
in induced sputum from patients with chronic
obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;
153:530-534.
52. Traves SL, Culpitt S, Russell REK, Barnes PJ, Donnelly LE. Elevated levels
of the chemokines GRO-
a
and MCP-1 in sputum samples from COPD
patients. Thorax 2002; 57:590-595.
53. Hay DWP, Sarau HM. Interleukin-8 receptor antagonists in pulmonary
diseases. Curr Opin Pharmacol 2001; 1:242-247.
54. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Rrieken JH, Hiemstra
PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways
inflammation in COPD. J Pathol 2000; 190:619-626.
55. SaettaM. Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S,
et al. Increased expression of the chemokine receptor CXCR3 and its ligand
CXCL10 in peripheral airways of smokers with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2002; 165:1404-1409.
